Login to Your Account



New International Nonproprietary Naming Scheme

WHO INN Group Planning to Grapple with Biosimilar Names

By Mari Serebrov
Washington Editor

Monday, October 21, 2013
regulatory.jpg

Given the power of a name and the fact that more biosimilars are moving through the global pipeline, the World Health Organization (WHO) is facing increased pressure this week to come up with a new international nonproprietary naming (INN) scheme for the follow-on drugs.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription